Brain edema formation was investigated in the vasopressin-deficient Brattleboro rat using a middle cere bral artery occlusion model of early ischemic injury. Wa ter and sodium accumulation after 4 h of ischemia were attenuated 36 and 20%, respectively, in the Brattleboro strain as compared to the control Long-Evans strain. This effect was independent of differences in animal size and state of hydration. In addition, measurements of ce rebral blood flow indicated that Brattleboro and Long Evans rats had equal levels of ischemia following middle cerebral artery occlusion. Systemic treatment of Brattle boro rats with vasopressin normalized their serum elec trolyte concentrations and osmolarity but did not alter sodium or water accumulation in the ischemic brain. In contrast, intraventricular administration of vasopressin in
The ionic composition of the extracellular fluid compartment of the central nervous system is main tained remarkably constant (Bradbury, 1979) . This suggests the presence of potent regulatory mecha nisms. It has been postulated that a central neuro endocrine system may monitor and regulate the electrolyte composition and volume of the brain, analogous to the hypothalamic control of systemic volume homeostasis (Raichle, 1981) . Many of the hormones involved in systemic volume regulation, such as vasopressin, atrial natriuretic peptide, and angiotensin II, are synthesized and released within the central nervous system (Buijs et aI., 1978; Phil lips, 1987; Zamir et aI., 1986) . These centrally re leased neuropeptides may act locally on adjacent target cells, or at more distant intracerebral sites Brattleboro rats increased edema formation to that seen in control rats. The reduced water and sodium accumu lation in Brattleboro rats subjected to middle cerebral ar tery occlusion may be related to alterations in blood brain barrier permeability since the blood-to-brain so dium flux was 36% less in the ischemic tissue of the Brattleboro as compared to the Long-Evans strain. These results support the hypothesis that central vaso pressin is a regulator of brain volume and electrolyte ho meostasis. Furthermore, our findings suggest a role for central vasopressin in the development of ischemic brain edema. Key Words: Brattleboro rat-Cerebral ischemia Vasopressin-Blood-brain barrier permeability Sodium-Middle cerebral artery occlusion.
following their distribution through the cerebro spinal fluid (Raichle, 1981) . The target tissues for this putative regulatory system are likely to include the brain capillary endothelium and the choroid plexus epithelium, cells of which are in contact with both the extracellular space of the brain and the systemic environment.
The principal hormone involved in the regulation of systemic volume is vasopressin. There is abun dant anatomical evidence to suggest that the brain is also a target organ for vasopressin. Immunohisto chemical studies have documented extrahypo physeal vasopressinergic pathways to the choroid plexus (Brownfield and Kozlowski, 1977) , circum ventricular organs (Buijs et aI., 1978) , ependyma of the third and lateral ventricles (Castel et aI., 1984) , and brain capillaries (J ajart et aI., 1984) . The locus ceruleus also has a rich vasopressinergic innerva tion, and vasopressin may regulate the activity of this important central regulatory nucleus (Berecek et aI., 1987; Weindl and Sofroniew, 1985) . Recep tors for vasopressin have been identified on choroid plexus epithelium (Tribollet et aI., 1988; van Leeu wen et aI., 1987) and brain capillary endothelium (Hess et aI., 1991; Kretzschmar and Ermisch, 1989; Pearl mutter et al., 1988) . Although the polarity with respect to the luminal versus abluminal side of the endothelial and epithelial cell has not been deter mined, these vasopressin receptors have character istics most consistent with the V 1 receptor found in tissues outside the kidney (Hess et aI., 1991; Tri bollet et al., 1988) .
Physiologic evidence for a role of vasopressin in brain extracellular fluid regulation was obtained by Raichle and Grubb (1978) , who showed an increase in blood-to-brain water flux following intraventric ular vasopressin injection in monkeys. This re sponse was independent of changes in cerebral blood flow, and intravenous administration of vaso pressin had no effect. D6czi et al. (1982) showed that intraventricular administration of vasopressin or the vasopressin agonist desmopressin increased brain water content in rats and ascribed this to the influence of vasopressin on capillary permeability. They hypothesized that the elevated CSF vaso pressin levels seen in conditions like subarachnoid hemorrhage could accentuate edema formation. Rosenberg et al. (1988) measured brain water and sodium and potassium content in cats 4 h after in jecting vasopressin into the caudate nucleus and found an increase in water and sodium content, which could be blocked by coadministration of a V I -receptor antagonist. They hypothesized that va sopressin release into the brain may be involved in brain edema formation and that V I -receptor antag onists may prove to be useful therapeutic tools. In contrast to these effects on brain water uptake, ad ministration of vasopressin either intraventricularly or intravenously decreases CSF production (Faraci et aI., 1988) , suggesting that the effects of vaso pressin on choroid plexus epithelium may be quite different from effects on brain capillaries.
Vasopressin is present in the cerebrospinal fluid, and its concentration is elevated in many human disorders associated with brain edema (Sorensen et aI., 1985) . This correlation had led to investigations concerning the role of vasopressin in brain edema formation. Although one study has demonstrated that edema formation from a cold-induced brain in jury is accelerated following intraventricular admin istration of pharmacologic doses of vasopressin (Reeder et al., 1986) , it is not known whether re lease of endogenous vasopressin accelerates edema formation.
The goal of the present study was to determine whether physiologic release of vasopressin influ ences the formation of brain edema during focal J Cereb Blood Flow Metab, Vol. 12, No.4, 1992 ischemia. Therefore, we measured brain water and electrolyte content in control (Long-Evans) and va sopressin-deficient (Brattleboro) rats following oc clusion of the middle cerebral artery. Since previ ous studies have suggested that blood-brain barrier permeability to sodium may limit ischemic edema formation (Betz et al., 1989) , we also determined the effect of vasopressin deficiency on blood-to brain sodium transport in this model. A preliminary report of this study has appeared previously (Dick inson and .
MATERIALS AND METHODS

Middle cerebral artery occlusion
Adult male Brattleboro and Long-Evans rats between 60 and 90 days of age were fasted for 8-16 h and then anesthetized with 50 mg/kg i.p. ketamine hydrochloride and 10 mg/kg i.p. xylazine. A heating pad and rectal tem perature probe were used to maintain body temperature at 37 ± 1°C from the time of anesthesia until the rats were awake.
The middle cerebral artery occlusion procedure was performed through an incision made midway between the right eye and ear as described previously (Bederson et aI., 1986) . The temporalis muscle was reflected from the cra nium, and the zygoma was cut near its posterior attach ment to the skull. Under the operating microscope, a 6-mm diameter right temporal craniectomy was per formed over the proximal aspect of the right middle ce rebral artery. The dura was incised and the arachnoid membrane over the vessel was removed. The middle ce rebral artery was occluded from 2 mm proximal to the olfactory tract to the inferior cerebral vein with microbi polar electrocautery. The temporalis muscle was re approximated and the skin incision closed.
Animals which awoke from anesthesia were reanesthe tized 0.5 h before the end of the experiment. In all exper imental groups, a catheter was placed in the femoral ar tery for monitoring blood pressure and for collecting a 0.5-ml blood sample for determination of hematocrit, se rum osmolarity, serum electrolyte and glucose concentra tions, and blood gases. In the cerebral blood flow and blood-brain barrier permeability experiments, a second femoral artery catheter was placed for continuous sam pling of the blood isotope concentration and a femoral vein catheter was placed for isotope injection. All rats were decapitated at either I or 4 h after the middle cere bral artery occlusion. The brains were quickly removed from the skull, the hemispheres divided, and the brain stem, hippocampus, and thalamus discarded. The telen cephalic tissue remaining was placed flat on a nonabsor bent surface and the portion inferior to the rhinal fissure was removed. Three samples were taken from the re maining tissue using 5-and 7-mm cork borers ( Fig. 1) . Tissue ipsilateral and contralateral to the middle cerebral artery occlusion were sampled separately. The center re gion was taken from the cortex and striatum underlying the middle cerebral artery immediately distal to the region of occlusion. The intermediate region was a ring of tissue surrounding the center zone, while the outer region con sisted of the remainder of the cortical tissue. 
Measurement of brain water and electrolyte contents
For determination of water and ion contents, the brain samples were placed on small pieces of preweighed alu minum foil, weighed, dried for 40-44 h at 100°C, and then weighed again. Water content was calculated as the dif ference between the wet and dry weights divided by the dry weight. Dried brain samples were subsequently ashed in a muffle oven at 400°C for 16-18 h. The residues were dissolved in water, and the sodium and potassium con tents were determined by flame photometry with cesium as an internal standard.
Brain water and ion contents were determined on both age-matched and weight-matched groups of Long-Evans and Brattleboro rats. In a second experimental group, hypovolemia and hypernatremia in the Brattleboro strain were corrected by the intraperitoneal infusion of water at a rate of 4 ml kg -I h -1 during the period of middle ce rebral artery occlusion. A second group of age-matched Long-Evans rats served as controls and did not receive intraperitoneal water.
The effect of systemic vasopressin administration on edema formation in Brattleboro rats was evaluated in a third experiment. Osmotic minipumps were implanted subcutaneously in the interscapular region under keta mine and xylazine anesthesia 24 h before middle cerebral artery occlusion. The pumps delivered 1 fl.l/h of 105 ng/fl.l arginine vasopressin subcutaneously (Kinter, 1982) . Brat tleboro rats with osmotic minipumps delivering normal saline served as the control group.
In a fourth experimental protocol, the effect of 24 h of intraventricular vasopressin administration in Brattleboro rats was examined. Rats were anesthetized 24 h before occlusion, and a 22-gauge cannula was inserted into the left lateral cerebral ventricle under stereotaxic guidance at the coordinates 0.6 mm anterior, 1.4 mm left, and 4.5 mm in depth relative to the bregma. The cannula was affixed to the skull with retaining screws and methyl methacrylate. The cannula was connected to an osmotic minipump which delivered 50 ng/fl.l arginine vasopressin in artificial CSF at a rate of 1 fl.lIh, and the incision was closed. Brattleboro rats receiving intraventricular artifi cial CSF served as controls.
Measurement of cerebral blood flow
The cerebral blood flow was measured in age-matched Brattleboro and Long-Evans rats using the 14C-butanol method previously described (Gjedde et aI., 1980; Martz et aI., 1990) . At 1 h following middle cerebral artery oc clusion, 7.5 fl.Ci of 14C-butanol was injected as a bolus into the femoral venous catheter while arterial blood was collected continuously. Exactly 10 s after injection, the animal was sacrificed by decapitation, and the brain was rapidly sampled as described above. Tissue was weighed and then solubilized in 300 fl.l of 1.0 M methylbenze thonium hydroxide. Radioactivity was measured using liquid scintillation spectroscopy.
The brain blood flow per mass of tissue, CBF, was calculated using the following equation:
where Cb(1) is the amount of 14C-butanol per gram brain tissue in the sample at time T, JCadt is the amount of radioactivity in the arterial sample, and F is the rate of arterial sample collection. An iterative method was used to correct Cb(1) for washout of butanol from the brain tissue during the 10-s circulation time, using the values for the peak appearance of butanol in arterial blood (4.8 s), the arterial decay coefficient (0.069/s), and the blood brain partition coefficient for butanol (0.77 mllg) that were determined previously (Martz et aI., 1990) .
Measurement of blood-brain barrier permeability
The permeability of the blood-brain barrier to 22N a and eH]aminoisobutyric acid (AlB) was measured in age matched groups of Long-Evans and Brattleboro control animals that did not undergo craniotomy and middle ce rebral artery occlusion and in similar groups subjected to 4 h of middle cerebral artery occlusion. The blood-to brain influx rate constants (K) for 22Na and [3H]AIB were determined using the graphical analysis method of Patlak et a1. (1983) as described previously (Ennis et aI., 1990) .
A mixture of 40 fl.Ci [3H]AIB and 20 fl.Ci 22Na in 100 fl.l saline was injected intravenously into rats and allowed to circulate for 4,7, 10, 14, or 18 min prior to decapitation.
The integral of radioactivity in blood, J C (t) dt, was mea sured by continuous arterial withdrawal from the femoral catheter at a constant rate. The experiment was termi nated by decapitation. A final plasma sample for isotope concentration was obtained [C (1)], and then the brain (Cb) was rapidly sampled as de�cribed above. Brain and blood samples were solubilized in 1.0 M methylbenze thonium hydroxide, and radioactivity was measured by scintillation spectroscopy. The influx rate constant (K;) w � s ca�culated as t�e slope of Cb/Cp(1) vs. J Cp dt/Cp (1) usmg linear regreSSIon.
Statistics
Because of the known variability in rat models of focal ischemia (Brint et aI., 1988) , control and experimental groups were done simultaneously with randomization of control and experimental animals. Data from all experi ments were expressed as mean ± SD. Within an experi mental group, results from the corresponding ipsilateral and contralateral samples in the same animal were com pared using Student's two-tailed t test for paired samples.
The differences between strains (Long-Evans vs. Brat tleboro) in the four experiments measuring water and ion contents, the cerebral blood flow study, and the perme ability measurements were compared using Student's two-tailed t test for unpaired data. The differences in the permeability experiment within a strain were compared using analysis of covariance and the Newmann-Keuls test. A probability value of <0. 05 was used to indicate significance.
Materials
Long-Evans and Brattleboro rats were obtained from Harlan Sprague-Dawley (Indianapolis, IN). eHlAIB and 22Na were purchased from DuPont-New England Nu clear (Boston, MA), arginine vasopressin from Peninsula Labs (Belmont, CA), and Alzet osmotic minipumps from Alza (Palo Alto, CA). All other chemicals were obtained from Sigma Chemical (St. Louis, MO).
RESULTS
Physiological variables
Physiological variables for untreated Brattleboro and Long-Evans rats that underwent middle cere bral artery occlusion and for those that served as unoperated controls are summarized in Table 1 . Brattleboro rats were smaller than Long-Evans rats of equivalent age. Animals undergoing middle cere bral artery occlusion had slightly lower mean blood pressures relative to the unoperated animals, but this variable was not different between the two strains.
Serum osmolarity and sodium were significantly greater in the Brattleboro rats, reflecting the di uretic consequence of diabetes insipidus in these animals ( Table 2 ). Despite recovering from anesthe sia by approximately 45 min following occlusion of the middle cerebral artery, neither Brattleboro nor Long-Evans rats were observed drinking in the 4 h interval prior to sacrifice. Serum hyperosmolarity and hypernatremia in the Brattleboro rats were suc cessfully corrected by intraperitoneal infusion of water at a rate of 4 ml kg-I h -I during the post occlusion period or by subcutaneous vasopressin infusion at a rate of 105 ng/h for 24 h prior to sac rifice. Intraventricular cannulation of Brattleboro rats and treatment with 50 nglh of vasopressin for 24 h also corrected serum sodium values to the normal range, whereas vehicle-treated animals remained hypernatremic. Serum potassium was significantly reduced in the Brattleboro rats that had osmotic pumps implanted 24 h prior to occlusion. This de crease was independent of vasopressin administra tion, occurring in both the treated and untreated groups.
Cerebral blood flow CBF was calculated from the butanol extraction in the three tissue zones of the nonischemic and ischemic hemispheres following 1 h of middle cere bral artery occlusion (Table 3) . CBF in the ischemic center, intermediate, and outer zones was reduced to 18, 48, and 65%, respectively, compared to the respective nonischemic zones in both Long-Evans and Brattleboro rats. The center, intermediate, and outer zones of the nonischemic and ischemic hemi spheres were not statistically different between the two strains. This suggests that the ischemic insult was equivalent in Long-Evans and Brattleboro rats undergoing middle cerebral artery occlusion.
Edema formation
The results of brain water and ion content deter minations after 4 h of middle cerebral artery occlu sion are summarized in Table 4 . Comparison of the nonischemic hemisphere to the corresponding isch emic hemisphere in each strain showed significant increases in water in all three regions. The increase in sodium content of the ischemic hemisphere was significant in all regions except the outer zone of the Brattleboro rats. Likewise, a decrease in potassium content was observed in all regions except the outer zone of the Long-Evans rats. As would be expected in this model of graded partial ischemia, the abso lute difference in water content and sodium content Values are mean ± SD; significant differences were determined by analysis of variance and the Newmann-Keuls test.
a MCAO = pooled animals from permeability and untreated water/electrolyte experiments that underwent middle cerebral artery occlusion.
b p < 0.001 for differences compared to Long-Evans rats. c p < 0.01, dp < 0.001 for differences between unoperated and MCAO groups. between ischemic and nonischemic hemispheres was greatest in the center region, less in the inter mediate region, and least in the outer region.
Comparison of the nonischemic regions in Long Evans rats to the corresponding nonischemic re gions in Brattleboro rats showed a slightly lower water content in the Brattleboro strain. This differ ence was significant in the outer region, but not in the center and intermediate zones. The difference in nonischemic water content was not altered with in traperitoneal water or systemic vasopressin re placement therapies (not shown). In contrast to the water content, the sodium and potassium contents in the nonischemic hemispheres were not different between the two strains.
Comparison of the ischemic hemisphere of Long Evans rats to the ischemic hemisphere of Brattle boro rats showed significantly lower water contents in all three regions of the Brattleboro strain. Sodium content was also lower in the ischemic Brattleboro rats, but it reached significance only in the center region. Attention was focused on the findings in the center zone in the remainder of the results. Figure 2 graphically summarizes the changes in water and electrolyte content between the ischemic and nonischemic center regions for Brattleboro and Long-Evans strains. The increases in water and so dium contents following 4 h of middle cerebral ar tery occlusion were significantly smaller in the Brattleboro rats when compared to the Long-Evans Values are mean ± SD and expressed as ml 100 g -1 min -1.
rats. The increase in water content in the Brattle boro center region was 0.65 ± 0.16 mllg, which was �36% less than the 1.03 ± 0. 35 mllg observed in the Long-Evans center region. The increase in sodium content in the center region of the Brattleboro rats was 216 ± 59 mEq/g, approximately 20% less than the 265 ± 39 mEq/g observed in the center region of the Long-Evans rats. The changes in potassium content were not statistically different between the two strains.
To determine if the measured difference in animal size was important in the formation of brain edema, a group of weight-matched Long-Evans animals (n = 9) were compared to the initial group of Brattle boro animals (data not shown). Once again, water accumulation 0.42 ± 0. 38 ml/g) and sodium accu mulation (293 ± 73 mEq/g) were significantly greater than in the Brattleboro group, and there was no difference in potassium loss between the strains.
To determine if the difference in edema formation was a consequence of the relative dehydration that results from diabetes insipidus, Brattleboro rats re ceived an intraperitoneal infusion of water at a rate of 4 ml kg -1 h -1 during the 4 h of middle cerebral artery occlusion. As seen in Table 2 , serum abnor malities were successfully corrected with this ther apy; however, the differences in edema formation remained (Fig. 3) .
Subcutaneous infusion of vasopressin also suc cessfully corrected electrolyte abnormalities in Brattleboro rats (Table 2) ; however, there were no differences in the amount of brain water or sodium accumulation between the control Brattleboro rats and those treated with subcutaneous vasopressin (Fig. 4A ). This suggests that systemic vasopressin at doses sufficient to alter renal water clearance did not affect brain edema formation.
The changes in brain water and sodium content in Brattleboro rats that received an intraventricular in fusion of vasopressin are summarized in Fig. 4B . There was a 75% increase in brain water content and a 48% increase in brain sodium content in rats treated with 24 h of intraventricular vasopressin when compared to a vehicle-treated Brattleboro Values are mean ± SO; significant differences between the ischemic and non ischemic hemispheres as measured by Student's paired, two-tailed t test are listed for each strain. ns, not significantly different.
a p < 0.05 and b p < 0.01 indicate differences compared to Long-Evans rats as measured by Student's two-tailed t test.
group, indicating that central vasopressin adminis tration enhanced edema formation in the Brattle boro strain. This dose also corrected the systemic electrolyte abnormalities of the Brattleboro rats (Table 2) , consistent with systemic circulation of the neuropeptide following this dose and method of infusion (Clark et at., 1983) . However, since sys temic administration of an even greater dose did not alter edema formation (Fig. 4A) , we conclude that the change induced by intraventricular infusion must represent a central effect of vasopressin.
Blood-brain barrier permeability to AlB and sodium Blood-brain barrier permeability to AIB ( Long-Evans control groups, 1.18 ± 0.12 IJ-I g-I min -I and 1.17 ± 0.19 IJ-I g-I min -I , respectively. Following craniectomy and right middle cerebral ar tery occlusion, Long-Evans rats demonstrated a significant increase in AIB influx in both the non ischemic (1.79 ± 0.19 IJ-I g-I min-I , p < 0.02) and ischemic (1.66 ± 0.19 IJ-I g-I min -I , P < 0.05) hemi spheres. Brattleboro rats showed no alteration in AIB influx in the nonischemic or ischemic hemi spheres compared to controls, and therefore, AIB influx was significantly lower when compared to the corresponding Long-Evans center region. This sug gests that the craniectomy and/or middle cerebral artery occlusion procedures induce a global in crease in blood-brain barrier permeability in both 4 h period of ischemia in Brat tleboro (shaded bars) rats. The mean d water or sodium con tent was calculated by subtract ing the value obtained in the nonischemic cortex from that of the ischemic cortex for each rat and then averaging the result for the group. Long-Evans rats (striped bars) served as controls and did not receive intraperi toneal hydration. *, p < 0.005; t, p < 0.001, compared to Long Evans rats.
Water Accumulation Sodium Accumulation ischemic and nonischemic brain tissue of Long Evans rats, but not in vasopressin-deficient Brattle boro rats. Blood-brain barrier permeability to sodium (Fig.  5B) was not significantly different in the unoperated Brattleboro and Long-Evans control groups, 1.26 ± 0.17 ,..d g-I min-I and 1.32 ± 0.17 , . .dg-1 min-I , respectively. Long-Evans rats demonstrated a sig nificant increase in sodium influx following middle cerebral artery occlusion in both the nonischemic (1.63 ± 0.22 J.Ll g-I min -\ p < 0.05) and ischemic hemispheres (3.03 ± 0.31 J.Ll g-I min -I , P < 0.001). Brattleboro rats showed stimulation of sodium in flux only in the ischemic hemisphere 0.97 ± 0.19 J.Ll g-l min -I , P < 0.025); however, the magnitude of this increase was 36% less than that observed in the Long-Evans strain. Changes in specific sodium transport were evaluated by calculating the ratio of the sodium influx rate divided by the AlB influx rate (Schielke et ai., 1991) . Consistent with our pre vious results (Betz and Coester, 1990; Schielke et ai., 1991) , sodium transport was increased �75% in the ischemic center region of both strains. There was no difference in this ratio in any of the groups between the strains.
DISCUSSION
Because of the possible role of vasopressin in reg ulation of brain water content, we chose to study the effect of vasopressin on brain edema formation and blood-brain barrier permeability using a strain of rat deficient in vasopressin. The Brattleboro strain, originally derived from the Long-Evans strain, has diabetes insipidus as the result of an au tosomal recessive defect in vasopressin gene regu lation (Majzoub et ai., 1987; Schmale and Richter, 1984) . The Brattleboro rat has no measurable vaso pressin in the blood or CSF (Majzoub et ai., 1987; Mohring and Mohring, 1975) and it is devoid of va sopressin immunoreactivity in neurons of the hypo thalamus and other brain regions (Sofroniew and Weindl, 1978; Vande sande and Dierickx, 1976) . However, Brattleboro rats do have central and pe ripheral vasopressin receptors, including receptors on cerebral microvessels (Kretzschmar and Er misch, 1989; van Zwieten et ai., 1988 ). This animal model allows one to study the effect of intrinsic vasopressin release on brain ion and water physiol ogy (DePasquale et ai., 1989; D6czi et ai., 1984) . Nevertheless, altered responses in this species may not result exclusively from vasopressin absence, since other hormone systems may be altered in a compensatory manner in this species (Sokol and Zimmerman, 1982) . Early brain edema formation was studied in a model of partial ischemia where the blood-brain barrier has been demonstrated to be intact (Schielke et ai., 1991) . Our purpose was to determine if in trinsic vasopressin accentuated ischemia-induced edema formation. The results indicate that the va sopressin-deficient Brattleboro rat develops less brain edema following 4 h of focal cerebral ischemia than the Long-Evans strain. There was an approx imate 3�50% reduction in water accumulation and a 20-25% reduction in sodium accumulation in the Brattleboro strain when compared to the Long Evans strain. There was no difference in ischemia induced potassium losses. Thus, vasopressin does not appear to affect the efflux of potassium as much as it enhances sodium and water accumulation. We could not measure a difference between the Brat tleboro and Long-Evans rats in the effect of middle cerebral artery occlusion on blood flow, suggesting Water Accumulation Sodium Accumulation that the ischemic insult in the two strains was iden tical. Therefore, it is not likely that the observed differences in edema formation and permeability were due to a strain difference in vascular anatomy or infarct volume. Interestingly, we found that there was less water in the nonischemic hemispheres of Brattleboro rats. This suggests that vasopressin deficiency may alter the water content of normal brain. However, the magnitude of this difference was quite small, and we did not find a difference in either sodium or AlB permeability when comparing unoperated animals, consistent with the finding of DePasquale et al. (1989) . Therefore, it does not appear that vaso pressin plays a significant role in blood-brain bar rier regulation of ion and water homeostasis under normal conditions. In disease states, however, va sopressin may play a very important role in brain volume regulation. As previously mentioned, brain J Cereb Blood Flow Metab, Vol. 12, No.4, 1992 mJury from multiple etiologies, including stroke, trauma, intracranial neoplasm, and intracerebral hemorrhage (Sorensen et aI., 1985) , has been asso ciated with significant elevations in CSF vaso pressin, which may be secondary to a hypothalamic response to changes in the extracellular volume composition. Pharmacologic doses of vasopressin delivered into the CSF or brain parenchyma have been shown to induce increases in brain water in the absence of cerebral injury (D6czi et aI., 1982; Rosenberg et aI., 1988; Rosenberg et aI., 1990) . Reeder et al. (1986) showed that vasopressin en hanced white matter edema formation following cold-induced injury, and DePasquale et aI., (1989) showed that hypernatremia-induced brain volume regulation was attenuated in vasopressin defi ciency. In our model of partial ischemic injury, we demonstrated that vasopressin deficiency attenu ated edema formation and that intraventricular re- placement of vasopressin normalized edema forma tion. Thus, it appears that edema formation is wors ened by the presence of vasopressin in the central nervous system. The mechanism by which vasopressin enhances edema formation was investigated by measuring ischemia-induced changes in the blood-brain bar rier permeability to sodium and aminoisobutyric acid, a passively permeable solute with an influx rate constant similar to that of sodium. The absence of vasopressin during ischemic injury in the rat pre vented increases in passive permeability, not only in the ischemic tissue, but also in nonischemic tis sue. This suggests that vasopressin in the central nervous system causes global changes in blood brain barrier permeability. Vasopressin-deficient rats also showed significant attenuation in sodium influx. The observed attenuation in the influx rate constants in Brattleboro rats compared to Long Evans rats was similar in magnitude for sodium and AlB, and therefore, the ratio of sodium to AlB per meabilities in the nonischemic and ischemic hemi spheres was not different between the two strains. This suggests that vasopressin does not selectively alter sodium transport. Rather, it appears to induce a generalized increase in the permeability of solutes and water at the blood-brain barrier, perhaps by opening trans cellular pathways to solute influx. Re gardless of the mechanism, the sodium influx in the ischemic cortex of the Brattleboro rat was 36% lower than that in the Long-Evans rat, and this dif ference in sodium permeability closely approxi mates the attenuation in sodium and water accumu lation demonstrated in the edema experiments. Since blood-brain barrier permeability to sodium may limit brain edema formation during the early stages of ischemia (Betz et aI., 1989) , the reduced brain edema accumulation in the Brattleboro rat may be explained by the reduced sodium permeabil ity of the blood-brain barrier.
